Advertisement

Topics

The Lustgarten Foundation for Pancreatic Cancer Research Company Profile

14:31 EST 24th February 2017 | BioPortfolio

Founded in 1998 by Cablevision executive Marc Lustgarten, with Cablevision chairman Charles Dolan and CEO James Dolan, The Lustgarten Foundation is the nation's largest private, non-profit supporter of pancreatic cancer research, providing more than $20 million to date. The Foundation provides patient information and manages a national public awareness campaign. To learn more and to see Dr. Pausch's PSA, visit www.lustgarten.org.


News Articles [8831 Associated News Articles listed on BioPortfolio]

Caris Life Sciences, Lustgarten Foundation collaborate

Caris Life Sciences, an innovator in molecular science, and the Lustgarten Foundation, a private funder of pancreatic cancer research, are collaborating to support a clinical trial evaluating the im...

Half of Americans Surveyed Think There is a Pancreatic Cancer Screening Test

BETHPAGE, N.Y., Nov. 17, 2016 /PRNewswire-USNewswire/ -- A nationwide omnibus survey revealed that 50 percent of Americans questioned believe there is a universal screening test for pancreatic ca...

Caris Life Sciences and the Lustgarten Foundation Collaborate to Support Immunotherapy Clinical Trial for Pancreatic Cancer

IRVING, Texas, Jan. 18, 2017 /PRNewswire/ -- Caris Life Sciences, a leading innovator in molecular science, and the Lustgarten Foundation, the largest private funder of pancreatic cancer research...

Researchers take important step forward in understanding how to treat pancreatic cancer

BETHPAGE, N.Y., Feb. 23, 2017 /PRNewswire-USNewswire/ -- Researchers have taken an important step forward in understanding why pancreatic cancer is so hard to treat. A new study published online ...

UK's Pancreatic Cancer Research Fund announces latest grant awards

(Pancreatic Cancer Research Fund) Five research projects with potential to make a real difference to tackling pancreatic cancer have been awarded grants by the UK charity Pancreatic Cancer Research Fu...

Pancreatic Cancer Action Invites Applicants for Research Funding

UK charity Pancreatic Cancer Action are once again inviting scientists to apply for one of their Early Diagnosis Challenge Award grants.  The purpose of these grants is to encourage mor...

Caris Life Sciences and the Lustgarten Foundation Collaborate to Support Immunotherapy Clinical ...

IRVING, Texas, Jan. 18, 2017/PRNewswire/ --  Caris Life Sciences,a leading innovator in molecular science, and the Lustgarten Foundation, the largest private funder Read more...

Discovery of blood biomarkers for early pancreatic cancer detection

Pancreatic cancer is one of the most lethal forms of cancer because early stage symptoms are relatively light, often resulting in it being discovered only after spreading to other organs. In order to ...

PubMed Articles [11607 Associated PubMed Articles listed on BioPortfolio]

Pancreatic cancer microenvironment.

Pancreatic cancer remains one of the deadliest solid tumors in humans and an unsolved problem of today's medicine. Experimental studies reveal that the heterogeneous and complex pancreatic cancer micr...

Treatment of pancreatic insufficiency using pancreatic extract in patients with advanced pancreatic cancer: a pilot study (PICNIC).

Survival with advanced pancreatic cancer is less than 12 months. Pancreatic exocrine insufficiency may contribute to pancreatic cancer-related cachexia, via nutrient malabsorption. We aimed to determ...

Host sphingosine kinase 1 worsens pancreatic cancer peritoneal carcinomatosis.

There are no effective treatments for pancreatic cancer peritoneal carcinomatosis (PC) or cancer dissemination in abdominal cavity. Sphingosine-1-phosphate (S1P), a bioactive lipid mediator produced b...

Antitumor Effects of Eribulin Mesylate in Gemcitabine-resistant Pancreatic Cancer Cell Lines.

One reason of poor survival rate of patients with pancreatic cancer is the development of chemoresistance. The aim of the present study was to investigate the effects of eribulin mesylate in gemcitabi...

Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials.

Pancreatic cancer is one of the most aggressive malignancies with dismal prognosis. Recently, aspirin has been found to be an effective chemopreventive agent for many solid tumors. However, the functi...

Clinical Trials [7829 Associated Clinical Trials listed on BioPortfolio]

EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer

This is a single-centre, prospective, non-randomised research study. The research team will investigate the feasibility of assessing primary human pancreatic tissue for changes to T lympho...

Pancreatic Cancer Registry: For Any Person With a Personal or Family History

The NFPTR was established in 1994 to find the causes of pancreatic cancer. In brief, the investigators are interested in both the genetic and non-genetic causes of pancreatic cancer. The i...

Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer

The purpose of this research study is to try to define the highest doses of temsirolimus and gemcitabine that can be used safely in combination to treat advanced pancreatic cancer. Gemcita...

K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability

This study is an open and single-center Phase I clinical research on patients with advanced pancreatic cancer, for evaluating their adverse reactions or tolerance to K-001, so as to determ...

A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response

Patients with pancreatic cancer are treated with combinations of surgery, radiation therapy and chemotherapy, depending on the location of the cancer and other individual patient health fa...

Companies [3722 Associated Companies listed on BioPortfolio]

The Lustgarten Foundation for Pancreatic Cancer Research

Founded in 1998 by Cablevision executive Marc Lustgarten, with Cablevision chairman Charles Dolan and CEO James Dolan, The Lustgarten Foundation is the nation's largest private, non-profit support...

The Lustgarten Foundation

The Lustgarten Foundation, based in Bethpage, New York, is America's largest private foundation dedicated solely to funding pancreatic cancer research. Founded in 1998, the Foundation provides critica...

Sky Foundation, Inc.

After being diagnosed with pancreatic cancer in 2007 and responding well to treatment, Kasselman established Sky Foundation to fund research for the Sky Foundation Pancreatic Cancer Research Fund at t...

Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organizat...

Pancreatic Cancer Action

About Pancreatic Cancer Action: 5 year survival rates for pancreatic cancer have not changed in over 40 years and it is our mission to change this by way of increased awareness of pancreatic cancer...

More Information about "The Lustgarten Foundation for Pancreatic Cancer Research" on BioPortfolio

We have published hundreds of The Lustgarten Foundation for Pancreatic Cancer Research news stories on BioPortfolio along with dozens of The Lustgarten Foundation for Pancreatic Cancer Research Clinical Trials and PubMed Articles about The Lustgarten Foundation for Pancreatic Cancer Research for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Lustgarten Foundation for Pancreatic Cancer Research Companies in our database. You can also find out about relevant The Lustgarten Foundation for Pancreatic Cancer Research Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record